139 related articles for article (PubMed ID: 11375267)
1. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
Patterson C; Stouffer GA; Madamanchi N; Runge MS
Circ Res; 2001 May; 88(10):987-97. PubMed ID: 11375267
[TBL] [Abstract][Full Text] [Related]
2. Thrombin activates NF-kappa B through thrombin receptor and results in proliferation of vascular smooth muscle cells: role of thrombin in atherosclerosis and restenosis.
Maruyama I; Shigeta K; Miyahara H; Nakajima T; Shin H; Ide S; Kitajima I
Ann N Y Acad Sci; 1997 Apr; 811():429-36. PubMed ID: 9186620
[TBL] [Abstract][Full Text] [Related]
3. Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway.
Du J; Brink M; Peng T; Mottironi B; Delafontaine P
Circ Res; 2001 May; 88(10):1044-52. PubMed ID: 11375274
[TBL] [Abstract][Full Text] [Related]
4. High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells.
Dangwal S; Rauch BH; Gensch T; Dai L; Bretschneider E; Vogelaar CF; Schrör K; Rosenkranz AC
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):624-33. PubMed ID: 21164077
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist.
Ahn HS; Foster C; Boykow G; Stamford A; Manna M; Graziano M
Biochem Pharmacol; 2000 Nov; 60(10):1425-34. PubMed ID: 11020444
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptors in vascular biology.
Coughlin SR
Thromb Haemost; 2001 Jul; 86(1):298-307. PubMed ID: 11487018
[TBL] [Abstract][Full Text] [Related]
7. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
[TBL] [Abstract][Full Text] [Related]
8. Thrombin signalling and protease-activated receptors.
Coughlin SR
Nature; 2000 Sep; 407(6801):258-64. PubMed ID: 11001069
[TBL] [Abstract][Full Text] [Related]
9. Thrombin stimulates smooth muscle cell procollagen synthesis and mRNA levels via a PAR-1 mediated mechanism.
Dabbagh K; Laurent GJ; McAnulty RJ; Chambers RC
Thromb Haemost; 1998 Feb; 79(2):405-9. PubMed ID: 9493599
[TBL] [Abstract][Full Text] [Related]
10. Thrombin, thrombomodulin, and extracellular signal-regulated kinases regulating cellular proliferation.
Freedman JE
Circ Res; 2001 Apr; 88(7):651-3. PubMed ID: 11304485
[No Abstract] [Full Text] [Related]
11. Transcellular signaling and pharmacological modulation of thrombin-induced production of plasminogen activator inhibitor-1 in vascular smooth muscle cells.
Shen GX; Ren S; Fenton JW
Semin Thromb Hemost; 1998; 24(2):151-6. PubMed ID: 9579636
[TBL] [Abstract][Full Text] [Related]
12. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
[TBL] [Abstract][Full Text] [Related]
13. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
Ivey ME; Little PJ
Thromb Res; 2008; 123(2):288-97. PubMed ID: 18571697
[TBL] [Abstract][Full Text] [Related]
14. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor.
Herkert O; Kuhl H; Sandow J; Busse R; Schini-Kerth VB
Circulation; 2001 Dec; 104(23):2826-31. PubMed ID: 11733402
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1.
Tsopanoglou NE; Maragoudakis ME
Semin Thromb Hemost; 2007 Oct; 33(7):680-7. PubMed ID: 18000795
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of protease-activated receptor-1 antagonists.
Derian CK; Maryanoff BE; Zhang HC; Andrade-Gordon P
Expert Opin Investig Drugs; 2003 Feb; 12(2):209-21. PubMed ID: 12556215
[TBL] [Abstract][Full Text] [Related]
18. A role for thrombin receptor signaling in endothelial cells during embryonic development.
Griffin CT; Srinivasan Y; Zheng YW; Huang W; Coughlin SR
Science; 2001 Aug; 293(5535):1666-70. PubMed ID: 11533492
[TBL] [Abstract][Full Text] [Related]
19. Rac1 regulation of surface expression of protease-activated receptor-1 and responsiveness to thrombin in vascular smooth muscle cells.
Yufu T; Hirano K; Bi D; Hirano M; Nishimura J; Iwamoto Y; Kanaide H
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1506-11. PubMed ID: 15860737
[TBL] [Abstract][Full Text] [Related]
20. Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells.
McEachron TA; Church FC; Mackman N
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):576-82. PubMed ID: 21799402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
